For COVID-19 and vaccination updates, view our information for the community. If you're experiencing symptoms, call your primary care provider.

Decorative dot pattern background image.
Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image.

Alliance A151216

Trial Overview

Official Title

Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

Study Purpose

To study the genes of tumor cells to determine if these results will help physicians select the best treatment options for patients with genetic changes. 

Diagnosis

Stage IB-IIIA Non-Small Cell Lung Cancer

Eligibility

Eastern Cooperative Oncology Group (ECOG) performance status 0-1

No prior chemotherapy or radiation therapy for this lung cancer

Patients must sign an approved informed consent and authorization permitting release of personal health information.

Intervention

For more information, visit ClinicalTrials.gov

Key Participation Requirements
Gender
Male or Female
Age
19 years and older
Enrollment Status
Recruiting
Phase
Phase III
Methodist Health System Trial Code
A151216